These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9563782)

  • 21. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesothelial pelvic lymph node inclusions mimicking metastatic thyroid carcinoma.
    Cohn DE; Folpe AL; Gown AM; Goff BA
    Gynecol Oncol; 1998 Feb; 68(2):210-3. PubMed ID: 9514806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
    Djordjevic B; Malpica A
    Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant mesothelioma eight years after a diagnosis of atypical mesothelial hyperplasia.
    Scurry J; Duggan MA
    J Clin Pathol; 1999 Jul; 52(7):535-7. PubMed ID: 10605410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions.
    Facchetti F; Lonardi S; Gentili F; Bercich L; Falchetti M; Tardanico R; Baronchelli C; Lucini L; Santin A; Murer B
    Virchows Arch; 2007 Sep; 451(3):669-80. PubMed ID: 17609977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Images in pathology. Benign hyperplastic mesothelial cells in lymph node.
    Pelosi G; Sonzogni A; Rosai J
    Int J Surg Pathol; 2007 Jul; 15(3):297-9. PubMed ID: 17652541
    [No Abstract]   [Full Text] [Related]  

  • 27. Diffuse hyperplastic mesothelial cells in multiple lymph nodes: case report with review of the literature.
    Peng L; Shen Q; Liu X; Wang J; Shi S; Yu B; Zhou X
    Int J Clin Exp Pathol; 2013; 6(5):926-31. PubMed ID: 23638225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of malignant mesothelioma by fine needle aspiration of a cervical lymph node. A case report.
    Ansari NA; Derias NW
    Acta Cytol; 2000; 44(1):70-4. PubMed ID: 10667164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benign mesothelial cells in lymph node.
    Colby TV
    Adv Anat Pathol; 1999 Jan; 6(1):41-8. PubMed ID: 10197237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions.
    Hasteh F; Lin GY; Weidner N; Michael CW
    Cancer Cytopathol; 2010 Apr; 118(2):90-6. PubMed ID: 20209622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peritoneal malignant mesothelioma metastatic to supraclavicular lymph nodes.
    Zannella S; Testi MA; Cattoretti G; Pelosi G; Zucchini N
    Int J Surg Pathol; 2014 Sep; 22(6):552-4. PubMed ID: 24474244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoplastic and non-neoplastic mesothelial proliferations in pelvic lymph nodes.
    Hsu YK; Parmley TH; Rosenshein NB; Bhagavan BS; Woodruff JD
    Obstet Gynecol; 1980 Jan; 55(1):83-8. PubMed ID: 7352068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endosalpingiosis in axillary lymph nodes: a possible pitfall in the staging of patients with breast carcinoma.
    Corben AD; Nehhozina T; Garg K; Vallejo CE; Brogi E
    Am J Surg Pathol; 2010 Aug; 34(8):1211-6. PubMed ID: 20631604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucicarminophilic histiocytosis (benign signet-ring cells) and hyperplastic mesothelial cells: two mimics of metastatic carcinoma within a single lymph node.
    Groisman GM; Amar M; Weiner P; Zamir D
    Arch Pathol Lab Med; 1998 Mar; 122(3):282-4. PubMed ID: 9823870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desmin and neural marker expression in mesothelial cells and mesotheliomas.
    Hurlimann J
    Hum Pathol; 1994 Aug; 25(8):753-7. PubMed ID: 7520015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-derived growth factor receptor immunoreactivity in mesothelioma and nonneoplastic mesothelial cells in serous effusions.
    Ascoli V; Scalzo CC; Facciolo F; Nardi F
    Acta Cytol; 1995; 39(4):613-22. PubMed ID: 7543232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node metastasis as the initial manifestation of malignant mesothelioma. Report of six cases.
    Sussman J; Rosai J
    Am J Surg Pathol; 1990 Sep; 14(9):819-28. PubMed ID: 2389813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.
    Duggan MA; Masters CB; Alexander F
    Acta Cytol; 1987; 31(6):807-14. PubMed ID: 2447718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long microvilli of mesothelioma are conspicuous in pleural effusions processed by Ultrafast Papanicolaou stain.
    Yang GC
    Cancer; 2003 Feb; 99(1):17-22. PubMed ID: 12589641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology.
    Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
    Hum Pathol; 2010 May; 41(5):745-50. PubMed ID: 20060157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.